What is the updated guidelines protocol for using rituximab (Rituxan) in the treatment of adults with pemphigus vulgaris who are refractory to or intolerant of conventional immunosuppressive therapies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 13, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the updated protocol for using rituximab (rituximab) in the treatment of adults with pemphigus vulgaris who are refractory to or intolerant of conventional immunosuppressive therapies?

What is the updated protocol for using rituximab (Rituxan) in the treatment of pemphigus vulgaris, particularly in patients with moderate to severe disease who are refractory to or intolerant of conventional immunosuppressive therapies?

What is the recommended rituximab (Rituxan) protocol for a patient with Pemphigus vulgaris?

What are the guidelines for rituximab (rituximab) dosing and platelet count monitoring in patients with pemphigus vulgaris?

What is the recommended treatment protocol for rituximab (rituximab) in a middle-aged or older adult patient with moderate to severe pemphigus vulgaris, considering potential comorbidities and medications?

What is the indication and result of the Magnetic Resonance Imaging (MRI) scan for a patient with a history of potential neurological disorders, cancer, or musculoskeletal injuries, and what are the subsequent treatment or follow-up plans?

What are the advantages of ketamine as an analgesic, particularly in patients with a history of substance abuse or those at risk of opioid addiction?

What is the recommended daily dose of magnesium for a typical adult patient with no significant medical history?

What is the management for a healthcare provider with a history of Hepatitis B (HB) vaccination, unknown Anti-HBs (Antibody to Hepatitis B surface antigen) titer, and no prior documentation of post-vaccination serologic response, who sustained a percutaneous needlestick injury from a known HBsAg (Hepatitis B surface antigen)-positive patient?

What is the recommended management for a male patient with a urinary tract infection (UTI)?

What is the recommended initial dose of Mounjaro (tirzepatide) for a patient currently taking 1mg of Ozempic (semaglutide)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.